ARCHIVES

CCOP Review Committee Member Objects To “Unwarranted Criticism”

This article is from The Cancer Letter archive.

Vol. 14 No. 10 | March 4, 1988

Download PDF Visit The Full Archive

Related Articles

Proteomics Promises Ways To Track Response To Therapy

April 25, 2003

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

AACR Unanimously Backs Tough Antismoking Measure

May 18, 1984

NIDDK Funds Trial On treatment Of Chronic Hepatitis C

August 13, 1999

Coalition Gives “Incomplete” To NCI, CDC Statistics, But Gets Low Grade From Critics

March 20, 1998

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

October 19, 1979